The Covid-19 vaccine Australia has invested in has been dealt a major setback after researchers uncovered a suspected serious adverse reaction in a trial participant.The vaccine, being developed by pharmaceutical giant AstraZeneca...
Full ArticleCovid-19 coronavirus: Canberra has ordered 84m doses of now paused trial vaccine
New Zealand Herald
0 shares
1 views
You might like
Related news coverage
Covid: J&J vaccine shows strong immune response
IndiaTimes
A single dose of Johnson & Johnson's experimental Covid-19 vaccine produced a strong immune response against the novel coronavirus..
Advertisement
More coverage
Coronavirus Vaccines: R&D Landscape – Analysis
Scientists edge closer to develop a vaccine against the SARS-CoV-2 corona virus and Indian pharmaceutical companies are in front..
Eurasia Review